Group 1 metabotropic glutamate receptor inhibition selectively blocks a prolonged Ca2+ elevation associated with age-dependent excitotoxicity

被引:19
作者
Attucci, S
Clodfelter, GV
Thibault, O
Staton, J
Moroni, F
Landfield, PW
Porter, NM
机构
[1] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA
[2] Univ Florence, Dept Farmacol, I-50139 Florence, Italy
关键词
hippocampus; cell culture; aging; NMDA; AlDA; neurotoxicity;
D O I
10.1016/S0306-4522(02)00002-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It has been recognized for some years that a prolonged Ca2+ elevation that is predictive of impending cell death develops in cultured neurons following excitotoxic insult. In addition, neurons exhibit enhanced sensitivity to excitotoxic insult with increasing age in culture. However, little is known about the processes that selectively regulate the post-insult Ca2+ elevation and therefore, it remains unclear whether it is associated specifically, with age-dependent toxicity. Here, we tested the hypothesis that a group I metabotropic glutamate receptor antagonist selectively modulates the prolonged Ca2+ elevation in direct association with its protective effects against excitotoxicity. Rat hippocampal Cultures of two ages (8-9 and 21-28 days in vitro) were exposed to a 5-min glutamate insult (400 muM in younger and 10 muM in older cultures) sufficient to kill > 50% of the neurons, and were treated with vehicle or the specific group I metabotropic glutamate receptor antagonist 1-aminoindan-1,5-dicarboxylic acid (AIDA; 1 mM), throughout and following the insult. Neuronal survival was quantified 24 h after insult. In parallel studies, neurons of similar age in culture were imaged ratiometrically with a confocal microscope during and for 60 min after the glutamate insult. A large post-insult Ca2+ elevation was present in older but not most younger neurons. The N-methyl-D-aspartate receptor antagonist, MK-801, blocked the Ca2+ elevation both during and following the insult. In contrast, AIDA blocked only the post-insult prolonged Ca2+ elevation in older neurons. Moreover, AIDA was neuroprotective in older but not younger cultures. From these results we suggest that the post-insult Ca2+ elevation is regulated differently from the Ca2+ elevation during glutamate insult and is modulated by group I metabotropic glutamate receptors. Further, the prolonged Ca2+ elevation appears to be directly linked to an age-dependent component of vulnerability. (C) 2002 IBRO. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:183 / 194
页数:12
相关论文
共 84 条
[1]   Developmental regulation of the recovery process following glutamate-induced calcium rise in rodent primary neuronal cultures [J].
Adamec, E ;
Didier, M ;
Nixon, RA .
DEVELOPMENTAL BRAIN RESEARCH, 1998, 108 (1-2) :101-110
[2]   Exacerbation of neuronal cell death by activation of group 1 metabotropic glutamate receptors: Role of NMDA receptors and arachidonic acid release [J].
Allen, JW ;
Vicini, S ;
Faden, AI .
EXPERIMENTAL NEUROLOGY, 2001, 169 (02) :449-460
[3]   GLUTAMATE-INDUCED NEURONAL DEATH - A SUCCESSION OF NECROSIS OR APOPTOSIS DEPENDING ON MITOCHONDRIAL-FUNCTION [J].
ANKARCRONA, M ;
DYPBUKT, JM ;
BONFOCO, E ;
ZHIVOTOVSKY, B ;
ORRENIUS, S ;
LIPTON, SA ;
NICOTERA, P .
NEURON, 1995, 15 (04) :961-973
[4]  
Attucci S., 1999, Society for Neuroscience Abstracts, V25, P841
[5]   Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges [J].
Attucci, S ;
Carlà, V ;
Mannaioni, G ;
Moroni, F .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (04) :799-806
[6]   RAT HIPPOCAMPAL NEURONS IN DISPERSED CELL-CULTURE [J].
BANKER, GA ;
COWAN, WM .
BRAIN RESEARCH, 1977, 126 (03) :397-425
[7]   Age-related decrease in the N-methyl-D-aspartate(R)-mediated excitatory postsynaptic potential in hippocampal region CA1 [J].
Barnes, CA ;
Rao, G ;
Shen, J .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :445-452
[8]   CALIBRATION OF INDO-1 AND RESTING INTRACELLULAR [CA](I) IN INTACT RABBIT CARDIAC MYOCYTES [J].
BASSANI, JWM ;
BASSANI, RA ;
BERS, DM .
BIOPHYSICAL JOURNAL, 1995, 68 (04) :1453-1460
[9]  
Blalock EM, 1999, J NEUROSCI, V19, P8674
[10]  
BLEAKMAN D, 1992, MOL PHARMACOL, V42, P192